Genmont Biotech reports Aug revenue of NT$30.3M vs NT$26.2M
Genmont Biotech Inc. reported 2026 revenue of NT$30,302,000 versus NT$26,236,000 in 2025. Jan-Aug revenue was NT$250,356,000 versus NT$269,499,000, per the Taiwan Stock Exchange.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.